4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001762572-26-000006
Chief Patient Officer sold 3,712 shares at an average $32.14 ($119,311)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hoitt Jason Chief Patient Officer | 2026-03-17 | Sale | −1,033 | $32.74 | $33,820 | 12,955 | D: show line 1 in the form |
| Hoitt Jason Chief Patient Officer | 2026-03-17 | Sale | −748 | $33.38 | $24,965 | 12,207 | D: show line 2 in the form |
| Hoitt Jason Chief Patient Officer | 2026-03-18 | Sale | −1,762 | $31.28 | $55,122 | 10,445 | D: show line 3 in the form |
| Hoitt Jason Chief Patient Officer | 2026-03-18 | Sale | −139 | $31.79 | $4,419 | 10,306 | D: show line 4 in the form |
| Hoitt Jason Chief Patient Officer | 2026-03-18 | Sale | −30 | $32.85 | $986 | 10,276 | D: show line 5 in the form |
| Open-market sales · 3,712 sh · avg $32.14 · $119,311 | |||||||
Loading xslF345X06/form4-03192026_090337.xml…